- Targeting the DNA damage response in hematological malignancies
Sanjay De Mel et al, 2024, Frontiers in Oncology CrossRef - Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer
Yu-Ling Lu et al, 2021, Cancers CrossRef - MicroRNAs and the DNA damage response: How is cell fate determined?
Hartwig Visser et al, 2021, DNA Repair CrossRef - Wee1 Inhibitor AZD1775 Effectively Inhibits the Malignant Phenotypes of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
Shuning Bi et al, 2019, Frontiers in Pharmacology CrossRef - Synthetic Lethality through the Lens of Medicinal Chemistry
Samuel H. Myers et al, 2020, Journal of Medicinal Chemistry CrossRef - Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives
Nadezda Zhdanovskaya et al, 2021, Cancers CrossRef